“

If someone would say this is the intellectual property of this company ... and putting high prices on the vaccines, so making it impossible or very difficult to have access, this of course can have an impact on the most vulnerable, we want to prevent some unilateral decision that can effect the opportunity to have treatments and vaccines for everyone.